Results 231 to 240 of about 149,899 (292)
Triggering Receptor Expressed on Myeloid Cells 2 (TREM2) promotes obstructive nephropathy progression by activating the β‐catenin signalling pathway, driving M2 macrophage polarisation, migration and fibrogenic gene expression. targeted inhibition of TREM2 thus represents a promising novel strategy against renal fibrosis.
Jia Wei +7 more
wiley +1 more source
Abstract Aims To characterise differences in dietary intake, glucose variability, and activity in free‐living healthcare shift workers with type 2 diabetes (T2D) across varying work conditions. Methods Healthcare shift workers with T2D were monitored over 10 days, covering night shifts, day shifts, and rest days.
Rachel Gibson +8 more
wiley +1 more source
Abstract Aims Continuous glucose monitoring (CGM) systems have become important technologies to improve glycaemia in people with type 1 diabetes (T1D). However, it has been shown that during rapid glucose change, sensor performance can deteriorate.
Sabrina Sanfilippo +11 more
wiley +1 more source
Polycythaemic panmyelosis in chronic myeloid leukaemia
British Journal of Haematology, EarlyView.
George Mason +5 more
wiley +1 more source
Mineralocorticoid receptor antagonists: Efficacy and safety in chronic kidney disease
Abstract The mineralocorticoid receptor (MR) has a multifaceted role in normal physiologic functions. However, research has uncovered the deleterious consequences of overactivation of the MR. It has been implicated in chronic kidney disease (CKD) via its strong association with glomerulosclerosis, interstitial fibrosis, proteinuria, and decline in ...
Amy K. Mottl +2 more
wiley +1 more source
Marked Increases in Continuous Glucose Monitor-Detected Hypoglycemia During a Seven-Day Water-Only Fast in Healthy Men and Women. [PDF]
Kolnes KJ +7 more
europepmc +1 more source
Clinical Characteristics and Glucocorticoids Efficacy in COVID-19 Patients with Type 2 Diabetes: A Multicenter Retrospective Study. [PDF]
Wu S +9 more
europepmc +1 more source
In Support of Venous Glucose as a Reference Matrix for Evaluating Continuous Glucose Monitoring Accuracy. [PDF]
Klonoff DC +12 more
europepmc +1 more source

